Payments to ROCHE Sample Clauses

Payments to ROCHE. Section 7.1. of the Agreement shall be amended and read as follows:
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Payments to ROCHE. 6.1 ENS shall pay to ROCHE for a Product, the following amounts in accordance with and at the times set out the following milestones Milestones (US$) Phase III Initiation US$ **** NDA Filing of first indication in US US$ **** NDA Filing of first indication in EU US$ **** First Commercial Sale in US US$ **** First Commercial Sale in EU US$ **** First time Net Sales exceed US$ **** US$ **** First time Net Sales exceed US$ **** US$ **** All milestone payments under Section 6.1. shall be payable within thirty (30) days as from achievement of the respective milestone by ENS but only once, irrespective if how many times such milestone is achieved.
Sample 1Sample 2Sample 3
Payments to ROCHE. 7.1. Subject to ROCHE’s option rights under this Agreement, the parties hereto agree that in consideration for the rights and licenses acquired by ENS under this Agreement, ENS shall pay to ROCHE for a Product the following amounts in accordance with and at the times set out as follows: *Portions of this document marked with **** have been omitted pursuant to a request for confidential treatment submitted with the SEC.
Sample 1Sample 2
Payments to ROCHE. 7.1. EVOTEC shall pay to ROCHE for a Compound developed for **** the following amounts as success fees in accordance with and at the times set out as follows: Milestones for **** Milestones (US$) Phase III Initiation US$ * *** NDA Filing of first indication in US US$ * *** NDA Filing of first indication in EU US$ * *** NDA Filing of first indication in Japan US$ * *** First Commercial Sale in US US$ * *** First Commercial Sale in EU US$ * *** First Commercial Sale in Japan US$ * *** First time annual Net Sales exceed US$ **** US$ * *** First time annual Net Sales exceed US$ **** US$ * *** First time annual Net Sales exceed US$ **** US$ * ***
Sample 1
Payments to ROCHE. For Enabled Products, 4DMT shall pay Roche a royalty on all net sales of such Product(s) by 4DMT, its Affiliates or licensees, with the royalty rate based on the stage of the Product effective date of such termination as follows: Stage of Product at effective date of termination Royalty rate [***] [***] % [***] [***] % [***] [***] % [***] [***] % [***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. subject to the following:
Sample 1
Payments to ROCHE. 7.1. EVOTEC shall pay to ROCHE for a Compound developed for Alzheimer’s Disease the following amounts as success fees in accordance with and at the times set out as follows: Milestones for Alzheimer’s Disease Milestones (US$) Phase III Initiation US$ * *** NDA Filing of first indication in US US$ * *** NDA Filing of first indication in EU US$ * *** NDA Filing of first indication in Japan US$ * *** First Commercial Sale in US US$ * *** First Commercial Sale in EU US$ * *** First Commercial Sale in Japan US$ * *** First time annual Net Sales exceed US$ **** US$ * *** First time annual Net Sales exceed US$ **** US$ * *** First time annual Net Sales exceed US$ **** US$ * ***
Sample 1
Payments to ROCHE. If Dicerna exercises its Cost Share Option, then Dicerna will be responsible for [* * *] as follows:
Sample 1
AutoNDA by SimpleDocs
Payments to ROCHE a) The following shall be added to Section 6.1
Sample 1
Payments to ROCHE 
Sample 1

Related to Payments to ROCHE

  • Payments to Xxxxxx In connection with the distribution of shares of the Fund, Xxxxxx will be entitled to receive: (a) payments pursuant to any Distribution Plan and Agreement from time to time in effect between the Fund and Xxxxxx with respect to the Fund or any particular class of shares of the Fund, (b) any contingent deferred sales charges applicable to the redemption of shares of the Fund or of any particular class of shares of the Fund, determined in the manner set forth in the then current Prospectus and Statement of Additional Information of the Fund and (c) subject to the provisions of Section 3 below, any front-end sales charges applicable to the sale of shares of the Fund or of any particular class of shares of the Fund, less any applicable dealer discount.

  • PAYMENTS TO OWNER Section 4.01 Remittances...................................................29 Section 4.02 Statements to Owner...........................................29 Section 4.03 Monthly Advances by Servicer..................................30 Section 4.04 Due Dates Other Than the First of the Month...................30 ARTICLE V

  • Payments to Recipients The Distributor is authorized under the Plan to pay Recipients (1) distribution assistance fees for rendering distribution assistance in connection with the sale of Shares and/or (2) service fees for rendering administrative support services with respect to Accounts. However, no such payments shall be made to any Recipient for any period in which its Qualified Holdings do not equal or exceed, at the end of such period, the minimum amount (“Minimum Qualified Holdings”), if any, that may be set from time to time by a majority of the Independent Trustees. All fee payments made by the Distributor hereunder are subject to reduction or chargeback so that the aggregate service fee payments and Advance Service Fee Payments do not exceed the limits on payments to Recipients that are, or may be, imposed by the FINRA Rules. The Distributor may make Plan payments to any “affiliated person” (as defined in the 0000 Xxx) of the Distributor if such affiliated person qualifies as a Recipient or retain such payments if the Distributor qualifies as a Recipient.

  • Payments to Seller With respect to each Pledged Timeshare Loan, the Borrower shall have (i) received such Pledged Timeshare Loan as a contribution to the capital of the Borrower by the Seller or (ii) purchased such Pledged Timeshare Loan from the Seller in exchange for payment (made by the Seller in accordance with the provisions of the Sale and Contribution Agreement) in an amount which constitutes fair consideration and reasonably equivalent value. No such sale shall have been made for or on account of an antecedent debt owed by the Seller to the Borrower and no such sale is or may be voidable or subject to avoidance under any section of the Bankruptcy Code.

  • Payments to Company Except as provided in Section 3 hereof, after the Trust has become irrevocable, Company shall have no right or power to direct Trustee to return to Company or to divert to others any of the Trust assets before all payment of benefits have been made to Plan participants and their beneficiaries pursuant to the terms of the Plan.

  • Payments to Originators With respect to each Receivable transferred to Seller under the Receivables Sale Agreement, Seller has given reasonably equivalent value to the applicable Originator in consideration therefor and such transfer was not made for or on account of an antecedent debt. No transfer by any Originator of any Receivable under the Receivables Sale Agreement is or may be voidable under any section of the Federal Bankruptcy Code.

  • Payments to Agent A payment by the Borrower to the Agent hereunder or any of the other Loan Documents for the account of any Bank shall constitute a payment to such Bank. The Agent agrees promptly to distribute to each Bank such Bank's pro rata share of payments received by the Agent for the account of the Banks except as otherwise expressly provided herein or in any of the other Loan Documents.

  • Payments to the Company Except as provided in Sections 3, 8, and 14 hereof, the Company shall have no right or power to direct the Trustee to return to the Company or to divert to others any of the Trust assets before all payment of benefits have been made to Participants and their Beneficiaries pursuant to the terms of the Arrangements.

  • Payments to Originator With respect to each Receivable transferred to Buyer hereunder, the Purchase Price received by Originator constitutes reasonably equivalent value in consideration therefor and such transfer was not made for or on account of an antecedent debt. No transfer by Originator of any Receivable hereunder is or may be voidable under any section of the Bankruptcy Reform Act of 1978 (11 U.S.C. §§ 101 et seq.), as amended.

  • PAYMENTS TO PURCHASER 52 ARTICLE VI....................................................................54

Time is Money Join Law Insider Premium to draft better contracts faster.